Background: Sushi repeat-containing protein X-linked 2 (SRPX2) is overexpressed in a variety of different tumor tissues and correlated with poor prognosis in patients Little research focuses on the role of SRPX2 expression in prostate cancer (PCa)  and the clinicopathological significance of the protein expression in this tumor is relatively unknown